Table 1.
Host and Treatment Factors Increasing Risk of Selected Medical Complications ≥ 5 Years After Diagnosis of Childhood Cancer
Medical Late Effect | Host Factor | Treatment Factor |
---|---|---|
Hypothyroidism8 | Female; older age at diagnosis (> 15 years) | Radiation to thyroid, any dose, increasing risk with increasing dose |
Hyperthyroidism8 | Time since diagnosis < 3 years | Radiation to thyroid ≥ 35 Gy |
Thyroid nodules8 | Female; time since diagnosis > 10 years | Radiation to thyroid ≥ 25 Gy |
Short stature (analysis limited to ALL survivors)13 | Female; diagnosis before puberty | Cranial radiation > 20 Gy; radiation to spine |
Short stature (analysis limited to brain tumor survivors)12 | Younger age at diagnosis (< 4 years) | Radiation to hypothalamic pituitary axis, any dose, increasing risk with increasing dose |
Overweight/obese15 | Female; younger age at diagnosis | Cranial radiation |
Acute ovarian failure6 | Diagnosis ≥ 12 years | Ovarian radiation > 10 Gy; procarbazine and cyclophosphamide |
Premature menopause7 | Older attained age | Ovarian radiation; alkylating agents |
Pulmonary fibrosis25 | Chest radiation; cyclophosphamide, bleomycin, busulfan, CCNU, and BCNU | |
Stroke31,32 | Smoking (Hodgkin's disease) | Mantle radiation > 40 Gy for Hodgkin's disease; cranial radiation > 30 Gy for brain tumor and leukemia |
Motor problems34 | Radiation > 50 Gy to frontal regions | |
Hearing loss34 | Radiation > 50 Gy to posterior fossa | |
Seizure disorder 34 | Radiation dose > 30 Gy to any cortical segment of brain |
Abbreviations: ALL, acute lymphoblastic leukemia; CCNU, lomustine; BCNU, carmustine.